Annexon, Inc.

ANNX chart

Annexon, Inc. news

• What's Driving the Geographic Atrophy Market Boom? Experts

  openPR.com · Oct 27, 9:28 AM EDT

• Annexon, Inc. Estimates – BOATS:ANNX

  TradingView · Oct 25, 2:02 PM EDT

• H.C. Wainwright raises Annexon stock price target on GBS approval prospects

  Investing.com Nigeria · Oct 21, 1:24 AM EDT

• Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

  Yahoo Finance · Oct 16, 5:34 PM EDT

• Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

  Yahoo Finance · Sep 24, 8:00 AM EDT

• Annexon to Participate in Upcoming September Investor Conferences

  Yahoo Finance · Sep 2, 8:00 AM EDT

• What Annexon (ANNX)'s Dual-Endpoint ARCHER II Update Means For Shareholders

  Yahoo Finance · Aug 24, 4:08 AM EDT

• Annexon (ANNX) Q2 2026 Earnings Call Transcript

  fool.com · Aug 19, 9:58 AM EDT

• Annexon (ANNX), What Is Behind Its Latest Update?

  Yahoo Finance · Aug 13, 2:13 PM EDT

• Annexon, Inc. Q2 2026 Earnings Call Summary

  app.moby.co · Aug 12, 4:56 PM EDT

• Annexon Q2 Earnings Call Highlights

  marketbeat.com · Aug 12, 9:03 AM EDT

• Annexon shares fall as second-quarter loss exceeds Wall Street forecasts

  investorshub.advfn.com · Aug 12, 7:33 AM EDT

Annexon, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-08-12
• 8-K8-K2026-08-12
• 8-K8-K2026-08-10
• 8-K8-K2026-08-06
• 8-K8-K2026-07-30
• 8-K8-K2026-06-12
• 10-Q10-Q2026-05-07
• 8-K8-K2026-05-07
• DEF 14ADEF 14A2026-04-27
• 10-K10-K2026-03-30
• 8-K8-K2026-03-30
• 8-K8-K2026-02-17

About Annexon, Inc.

Ticker

ANNX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Brisbane, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1528115

Frequently asked questions